Immunotherapy for Children At Risk – Type 1 Diabetes
Returning guest, Dr. Adriana Carrillo-Iregui, pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital discusses immunotherapy for at risk children that is an emerging treatment for Type 1 diabetes. She explains how it works and which pediatric patients are candidates for this drug.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Diabetes. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Diabetes and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Diabetes?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Carrillo-Iregui is a pediatric endocrinologist within the Division of Pediatric Endocrinology at Nicklaus Children’s Hospital. Dr. Carrillo-Iregui received her medical degree at the Universidad El Bosque in Bogota, Colombia and completed a pediatric residency at Nicklaus Children’s Hospital followed by a fellowship in pediatric endocrinology at the University of Miami, Jackson Memorial Hospital. She is board certified in pediatrics and pediatric endocrinology. Before joining Nicklaus Children’s she was an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Miami, Miller School of Medicine. Her research and clinical interest has focused on metabolic disorders related to obesity, polycystic ovarian syndrome and type 2 diabetes. She has published extensively and lectured nationally and internationally.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
